Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Retroperitoneal Fibrosis
- Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
- The Effect and Safety of Tocilizumab Treatment on IRPF
- A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
- A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
- Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
- Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
- Treatment of IgG4-Related Disease With Revlimid and Rituximab
- Rituximab in IgG4-RD: A Phase 1-2 Trial
- Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
- Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis